PRRT2 and metabolic disease: We hope to provide a theoretical framework for researchers in the fields of neuroscience, metabolic disease, immunology, and drug discovery and development and ultimately promote the development of PKC‐targeted precision therapeutic strategies, bringing new breakthroughs in the study of the mechanisms and treatment of complex diseases.